NEW YORK ( TheStreet) -- Conceptus (Nasdaq: CPTS) hit a new 52-week high Monday as it is currently trading at $16.07, above its previous 52-week high of $15.72 with 7,077 shares traded as of 9:30 a.m. ET. Average volume has been 181,900 shares over the past 30 days. Conceptus has a market cap of $435.9 million and is part of the health care sector and health services industry. Conceptus, Inc. designs, develops, and markets minimally invasive devices for reproductive medical applications primarily in the United States, France, and rest of Europe. It primarily provides Essure, a permanent birth control system that delivers an insert into a woman's fallopian tubes.
TheStreet Ratings rates Conceptus as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in net income and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and a generally disappointing performance in the stock itself. You can view the full Conceptus Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center.